---
title: "Biotech brief: Gilead court win, Eli Lilly expands retatrutide access, and related biotech updates"
id: "stat-news-0-stat-three-biotechs-with-three-news-updates"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-three-biotechs-with-three-news-updates"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/08/04/biotech-news-gilead-wins-case-that-scrutinized-pace-of-drug-development/?utm_campaign=rss"
published_at: "2026-08-04T15:54:53.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Biotech brief: Gilead court win, Eli Lilly expands retatrutide access, and related biotech updates
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-three-biotechs-with-three-news-updates
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/08/04/biotech-news-gilead-wins-case-that-scrutinized-pace-of-drug-development/?utm_campaign=rss)
- **Published At:** 2026-08-04T15:54:53.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This STAT+ article, dated Aug. 4, 2026 and written by Elaine Chen, summarizes three biotech developments, headlined as: **Gilead wins case over its HIV medicine**, **Eli Lilly to expand access to retatrutide**, and other biotech news. - The piece is paywalled as a STAT+ exclusive; the full reporting and additional details are behind the subscription gate. The visible content on the page includes headline, byline, date, and an introductory paragraph about Lilly. - On Eli Lilly and retatrutide: the article reports that Lilly previously granted a single 79-year-old patient special access to its next-generation obesity drug **retatrutide**, and that the company now says it will allow other patients to apply for early or special access to the therapy. - The headline also indicates a legal development: **Gilead** prevailed in a court case concerning one of its HIV medicines. The article’s visible text does not provide specifics about the case, the drug, the court, or implications. - The page lists a brief “need-to-know” earnings note referencing **Vertex**, **Pfizer**, and **Merck**, but no further financial detail is presented in the visible excerpt. - Multiple links and related STAT pieces are shown on the page, including earlier STAT reporting on Lilly’s single-patient access and related STAT+ stories, indicating broader coverage across STAT about retatrutide and biotech industry developments. - Several standard webpage elements appear (newsletter sign-up, most-read links, subscription prompts, and related stories). The article clearly marks itself as exclusive content for STAT+ subscribers; the remainder of substantive content was not available in the publicly visible excerpt. - Where the source does not report details (court specifics for Gilead, scope and criteria for Lilly’s expanded access program, timelines, regulatory or clinical context, and quotes), those particulars are not reported in the visible source and therefore are not included here.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/08/04/biotech-news-gilead-wins-case-that-scrutinized-pace-of-drug-development/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/STAT10-Years-White.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-10.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/04/biotech-news-gilead-wins-case-that-scrutinized-pace-of-drug-development/?utm_campaign=rss) [FDA](https://www.statnews.com/topic/fda/) [CMS](https://www.statnews.com/topic/cms/) [research](https://www.statnews.com/topic/research/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-10.svg) A decade of reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-10.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)Newsletter[The Readout](https://www.statnews.com/category/readout-newsletter/) # Three biotechs with three news updates ## Gilead wins case over its HIV medicine, Eli Lilly to expand retatrutide access, and more biotech news * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/04/biotech-news-gilead-wins-case-that-scrutinized-pace-of-drug-development/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2017/09/AP17271744764601-645x645.jpg) Darron Cummings/AP ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) Aug. 4, 2026 National Biotech Reporter ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) 1. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") 2. [](https://x.com/elaineywchen "X") elaine.chen@statnews.com Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes [The Readout newsletter](https://www.statnews.com/signup/readout/), and co-hosts STAT’s weekly biotech podcast, [The Readout Loud](https://www.statnews.com/category/readout-loud/). You can reach Elaine on Signal at elaineywchen.70. _Want to stay on top of the science and politics driving biotech today?[Sign up](https://www.statnews.com/signup/readout/) to get our biotech newsletter in your inbox._ Good morning. I’ve decided to paint the walls in one of my rooms a dark brown. I may deeply regret this decision. Please send any painting tips! Advertisement ## The need-to-know this morning * Earnings: [**Vertex,**](https://news.vrtx.com/news-releases/news-release-details/vertex-reports-second-quarter-2026-financial-results) [](https://s206.q4cdn.com/795948973/files/doc_financials/2026/q2/Q2-2026-PFE-Earnings-Release-FINAL.pdf)[Pfizer](https://s206.q4cdn.com/795948973/files/doc_financials/2026/q2/Q2-2026-PFE-Earnings-Release-FINAL.pdf), and [Merck](https://www.merck.com/news/merck-highlights-key-regulatory-and-clinical-milestones-across-broad-diverse-pipeline/). ## Lilly will review applications for special access to experimental drug Over a month ago, STAT reported that Eli Lilly had [granted a single 79-year-old patient](https://www.statnews.com/2026/06/23/eli-lilly-unusual-weight-loss-drug-trial-compassionate-use-retatrutide-trump/) special access to its next-gen obesity drug retatrutide. Now, the pharma company says it will allow other patients to apply for early access to the therapy as well. [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [drug development](https://www.statnews.com/topic/drug-development/), [Drug prices](https://www.statnews.com/topic/drug-prices/), [research](https://www.statnews.com/topic/research/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) 1. [](https://x.com/elaineywchen "X") 2. [](https://bsky.app/profile/elaineywchen.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") National Biotech Reporter 1. [](https://x.com/elaineywchen "X") 2. [](https://bsky.app/profile/elaineywchen.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes [The Readout newsletter](https://www.statnews.com/signup/readout/), and co-hosts STAT’s weekly biotech podcast, [The Readout Loud](https://www.statnews.com/category/readout-loud/). You can reach Elaine on Signal at elaineywchen.70. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Morning-Rounds-Logo-Black-640x295.png) ### Newsletter Understand how science, health policy, and medicine shape the world every day Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/07/AdobeStock_2111261602_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Eli Lilly to allow more patients to apply for special access to unapproved obesity drug](https://www.statnews.com/2026/08/03/eli-lilly-retatrutide-mystery-patient-doctors-seek-same-access-their-patients/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-1993689815-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Kennedy and Oz call Medicaid cuts ‘myths.’ It’s more complicated than that](https://www.statnews.com/2026/08/04/rfk-medicaid-cuts-myth-analysis/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_1686467398_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Medicare eliminates key pathways used by ‘breakthrough’ devices for extra payments](https://www.statnews.com/2026/08/03/cms-fda-breakthrough-devices-payment-pathways-eliminated/) 4. ![](https://www.statnews.com/wp-content/uploads/2015/12/Raredisease-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [The latest orphan drug exemptions may not be warranted, analysis finds](https://www.statnews.com/pharmalot/2026/08/04/latest-orphan-drug-exemptions-may-not-be-warranted-analysis-finds/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-1134555885-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [As Trump administration pushes court-ordered mental health care, a new report raises questions](https://www.statnews.com/2026/08/04/new-report-questions-new-york-program-court-ordered-mental-healthcare/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2025/08/VCFirms2025_LeftRailUnit-328x426.png) 2025 Edition: Ranking Biotech’s Top Venture Capital Firms ](https://reports.statnews.com/products/biotech-top-venture-capital-firms-2025) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/06/2026AAIC_Wordpress_CalendarImage-80x80.jpg) AAIC Recap: What’s Next in Alzheimer’s Virtual Jul 16 ](https://www.statnews.com/event/2026-aaic-recap-alzheimers-conference/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_OfficeHours_VirtualEvent_Wordpress_CalendarImage-1-80x80.jpg) Office Hours with STAT’s Bob Herman Virtual Jul 22 ](https://www.statnews.com/event/out-of-pocket-series-bob-herman-office-hours-ama-july-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/07/AdobeStock_2111261602_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Eli Lilly to allow more patients to apply for special access to unapproved obesity drug](https://www.statnews.com/2026/08/03/eli-lilly-retatrutide-mystery-patient-doctors-seek-same-access-their-patients/) 2. ![](https://www.statnews.com/wp-content/uploads/2019/04/Duchenne-muscular-dystrophy-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA expert panel recommends against approval of Capricor’s Duchenne drug](https://www.statnews.com/2026/07/29/capricor-therapeutics-deramiocel-fda-review-meeting-live-blog/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/06/conference-center-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [American Diabetes Association, facing calls for resignations, asks for patience](https://www.statnews.com/2026/07/28/american-diabetes-association-fallout-researchers-expulsion/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/07/MUGSHOT_01-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A most-wanted fugitive appears to have been secretly working as a biotech executive](https://www.statnews.com/2026/07/20/ronald-fischer-rhode-island-fugitive-richard-graydon-biotech/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/07/fischer-3-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [In the biotech industry, a most-wanted fugitive was long hiding in plain sight](https://www.statnews.com/2026/07/29/ronald-fischer-fugitive-used-alias-forged-cv-held-biotech-executive-jobs/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Exclusive Exclusive August 3, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Eli Lilly to allow more patients to apply for special access to unapproved obesity drug ](https://www.statnews.com/2026/08/03/eli-lilly-retatrutide-mystery-patient-doctors-seek-same-access-their-patients/) By [Lizzy Lawrence](https://www.statnews.com/staff/lizzy-lawrence/) and [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout August 3, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Is there a pharma mega-merger in the making? ](https://www.statnews.com/2026/08/03/biotech-news-is-there-a-pharma-mega-merger-coming-astrazeneca-bms/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 3, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: BioNTech names Guido Oelkers its new CEO ](https://www.statnews.com/2026/08/03/biontech-ceo-guido-oelkers-ugur-sahin-replacement/) By [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) First Opinion First Opinion July 31, 2026 ### [ Limb girdle muscular dystrophy patients face a maddening reality ](https://www.statnews.com/2026/07/31/fda-platform-designation-hold-limb-girdle-muscular-dystrophy-lgmd/) By Kat Bryant Knudson ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech July 30, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA expert committee votes in favor of Replimune’s melanoma treatment ](https://www.statnews.com/2026/07/30/replimune-melanoma-drug-rp1-fda-expert-meeting-live-blog/) By [Matthew Herper](https://www.statnews.com/staff/matthew-herper/) and [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Clinical chatbots are taking medicine by storm. Should doctors trust them? ](https://www.statnews.com/2026/07/29/clinical-ai-vs-generalist-llm-benchmark-study-trust-accuracy-safety/) By [Katie Palmer](https://www.statnews.com/staff/katie-palmer/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA expert panel recommends against approval of Capricor’s Duchenne drug ](https://www.statnews.com/2026/07/29/capricor-therapeutics-deramiocel-fda-review-meeting-live-blog/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) and [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Dementia finally has a business model ](https://www.statnews.com/2026/07/28/brain-infrastructure-dementia-business-model-aaic2026/) By Jason Karlawish 4. ### [ The VA could help America win the biotechnology race with China ](https://www.statnews.com/2026/07/29/biotech-race-china-veterans-affairs-va/) By David Shulkin 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: In the biotech industry, a most-wanted fugitive was long hiding in plain sight ](https://www.statnews.com/2026/07/29/ronald-fischer-fugitive-used-alias-forged-cv-held-biotech-executive-jobs/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) Share options * [ X ](https://twitter.com/intent/tweet?url=https://www.statnews.com/2026/08/04/biotech-news-gilead-wins-case-that-scrutinized-pace-of-drug-development/&via=statnews&text=T
## Related Clinical Research

- [Handshake in Medicine: Why Clinicians Should Reconsider Shaking Hands](https://medichelpline.com/clinical-feed/stat-news-4-opinion-medicine-stopped-shaking-hands-we-should-start-again.md)
- [Lil Nas X’s bipolar diagnosis and the treatment paradox: fears, evidence, and outcomes](https://medichelpline.com/clinical-feed/stat-news-1-opinion-lil-nas-x-s-bipolar-diagnosis-and-the-paradox-of-treatment.md)
- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)
- [Coffee consumption associated with lower visceral fat, higher muscle mass, and hormonal differences](https://medichelpline.com/clinical-feed/medical-news-today-0-coffee-drinking-linked-to-less-abdominal-fat-more-muscle-better-hormone-balance.md)
- [Cardiac-targeted delivery strategies for advanced therapies in heart disease](https://medichelpline.com/clinical-feed/pubmed-42284133.md) (DOI: 10.1093/eurheartj/ehag432)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.